JAK inhibitor safety compared to traditional systemic immunosuppressive therapies

被引:0
|
作者
Bunick, Christopher [1 ,2 ]
Daniele, Stefano [3 ]
机构
[1] Yale Univ, Dept Dermatol, New Haven, CT USA
[2] Yale Univ, Program Translat Biomed, New Haven, CT USA
[3] Yale Sch Med, Med Scientist Training Program, New Haven, CT USA
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
43852
引用
收藏
页码:AB60 / AB60
页数:1
相关论文
共 50 条
  • [41] Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in myelofibrosis
    Pardanani, A.
    Laborde, R. R.
    Lasho, T. L.
    Finke, C.
    Begna, K.
    Al-Kali, A.
    Hogan, W. J.
    Litzow, M. R.
    Leontovich, A.
    Kowalski, M.
    Tefferi, A.
    LEUKEMIA, 2013, 27 (06) : 1322 - 1327
  • [42] Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in myelofibrosis
    A Pardanani
    R R Laborde
    T L Lasho
    C Finke
    K Begna
    A Al-Kali
    W J Hogan
    M R Litzow
    A Leontovich
    M Kowalski
    A Tefferi
    Leukemia, 2013, 27 : 1322 - 1327
  • [43] Targeted Systemic Therapies for Adults with Atopic Dermatitis: Selecting from Biologics and JAK Inhibitors
    Kim, Richard W.
    Lam, Megan
    Abuabara, Katrina
    Simpson, Eric L.
    Drucker, Aaron M.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2024, 25 (02) : 179 - 193
  • [44] Psoriasis drug failure rates of biologics compared to conventional systemic therapies
    Au, S.
    Levin, A. A.
    Gottlieb, A. B.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 : S9 - S9
  • [45] Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
    Crispin, Milene Kennedy
    Ko, Justin M.
    Craiglow, Brittany G.
    Li, Shufeng
    Shankar, Gautam
    Urban, Jennifer R.
    Chen, James C.
    Cerise, Jane E.
    Jabbari, Ali
    Winge, Marten C. G.
    Marinkovich, M. Peter
    Christiano, Angela M.
    Oro, Anthony E.
    King, Brett A.
    JCI INSIGHT, 2016, 1 (15):
  • [46] Efficacy and Safety of JAK1 Inhibitor Abrocitinib in Atopic Dermatitis
    Iznardo, Helena
    Roe, Esther
    Serra-Baldrich, Esther
    Puig, Lluis
    PHARMACEUTICS, 2023, 15 (02)
  • [47] Efficacy and Safety of Analgosedation with Fentanyl Compared to Traditional Sedation with Propofol
    Edwin, Stephanie
    Tedders, Kristen
    McNorton, Kelly
    CRITICAL CARE MEDICINE, 2013, 41 (12)
  • [48] Efficacy and Safety of Analgosedation with Fentanyl Compared with Traditional Sedation with Propofol
    Tedders, Kristen M.
    McNorton, Kelly N.
    Edwin, Stephanie B.
    PHARMACOTHERAPY, 2014, 34 (06): : 643 - 647
  • [49] The safety of alefacept used in combination with conventional systemic psoriasis therapies
    Cather, J
    Mann, J
    Abramovits, W
    Menter, A
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P199 - P199
  • [50] Safety of conventional systemic therapies for psoriasis on reproductive potential and outcomes
    Yiu, Zenas Z. N.
    Warren, Richard B.
    Mrowietz, Ulrich
    Griffiths, Christopher E. M.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2015, 26 (04) : 329 - 334